Skip to main content
Print Save

Carbetapentane / phenylephrine / pyrilamine Pregnancy and Breastfeeding Warnings

Carbetapentane / phenylephrine / pyrilamine is also known as: C-Tanna 12D, Tannate 12D S, Tannihist-12D, Tussi-12D, Tussi-12D S

Carbetapentane / phenylephrine / pyrilamine Pregnancy Warnings

Carbetapentane/phenylephrine/pyrilamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane/phenylephrine/pyrilamine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Carbetapentane / phenylephrine / pyrilamine Breastfeeding Warnings

There are no data on the excretion of carbetapentane/phenylephrine/pyrilamine into human milk. The manufacturer recommends that due to the potential for adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Tussi-12D (carbetapentane/phenylephrine/pyrilamine)." Meda AB (2005):
  2. "Product Information. Tussi-12D S (carbetapentane/phenylephrine/pyrilamine)." Meda AB (2005):

References for breastfeeding information

  1. "Product Information. Tussi-12D (carbetapentane/phenylephrine/pyrilamine)." Meda AB (2005):
  2. "Product Information. Tussi-12D S (carbetapentane/phenylephrine/pyrilamine)." Meda AB (2005):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer